GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Cyclically Adjusted Price-to-FCF

Embla Medical hf (OCSE:EMBLA) Cyclically Adjusted Price-to-FCF : 27.67 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Cyclically Adjusted Price-to-FCF?

As of today (2024-05-26), Embla Medical hf's current share price is kr28.50. Embla Medical hf's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was kr1.03. Embla Medical hf's Cyclically Adjusted Price-to-FCF for today is 27.67.

The historical rank and industry rank for Embla Medical hf's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

OCSE:EMBLA' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 25.49   Med: 45.71   Max: 77.36
Current: 27.54

During the past years, Embla Medical hf's highest Cyclically Adjusted Price-to-FCF was 77.36. The lowest was 25.49. And the median was 45.71.

OCSE:EMBLA's Cyclically Adjusted Price-to-FCF is ranked better than
63.48% of 230 companies
in the Medical Devices & Instruments industry
Industry Median: 44.1 vs OCSE:EMBLA: 27.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Embla Medical hf's adjusted free cash flow per share data for the three months ended in Mar. 2024 was kr-0.117. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is kr1.03 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Embla Medical hf Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Embla Medical hf's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cyclically Adjusted Price-to-FCF Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.19 60.10 47.03 34.76 26.47

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.34 31.49 27.97 26.47 32.37

Competitive Comparison of Embla Medical hf's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted Price-to-FCF falls into.



Embla Medical hf Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Embla Medical hf's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=28.50/1.03
=27.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Embla Medical hf's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.117/144.9095*144.9095
=-0.117

Current CPI (Mar. 2024) = 144.9095.

Embla Medical hf Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.203 98.777 0.298
201409 0.329 98.734 0.483
201412 0.264 98.669 0.388
201503 -0.032 99.612 -0.047
201506 0.178 100.289 0.257
201509 0.205 100.607 0.295
201512 0.291 100.657 0.419
201603 0.080 101.115 0.115
201606 0.054 101.923 0.077
201609 0.248 102.457 0.351
201612 0.264 102.562 0.373
201703 0.035 102.768 0.049
201706 0.206 103.496 0.288
201709 0.210 103.871 0.293
201712 0.357 104.481 0.495
201803 -0.064 105.600 -0.088
201806 0.140 106.206 0.191
201809 0.270 106.727 0.367
201812 0.234 108.388 0.313
201903 0.063 108.702 0.084
201906 0.278 109.758 0.367
201909 0.580 109.922 0.765
201912 0.102 110.588 0.134
202003 0.266 111.019 0.347
202006 0.306 112.667 0.394
202009 0.334 113.772 0.425
202012 0.159 114.542 0.201
202103 0.142 115.833 0.178
202106 0.317 117.451 0.391
202109 0.196 118.723 0.239
202112 0.436 120.398 0.525
202203 0.076 123.555 0.089
202206 0.025 127.809 0.028
202209 0.212 129.810 0.237
202212 0.262 131.901 0.288
202303 -0.037 135.674 -0.040
202306 0.172 139.150 0.179
202309 0.287 140.147 0.297
202312 0.414 142.125 0.422
202403 -0.117 144.910 -0.117

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Embla Medical hf  (OCSE:EMBLA) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Embla Medical hf Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines